|
|
|
Volumn 26, Issue , 1996, Pages 114-126
|
|
Clinical development plan: genistein.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
GENISTEIN;
ISOFLAVONE DERIVATIVE;
ANIMAL;
ARTICLE;
BREAST TUMOR;
DRUG APPROVAL;
EXPERIMENTAL NEOPLASM;
FEMALE;
HUMAN;
MALE;
METHODOLOGY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PROSTATE TUMOR;
RAT;
TOXICITY TESTING;
ANIMALS;
ANTICARCINOGENIC AGENTS;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
DRUG APPROVAL;
FEMALE;
GENISTEIN;
HUMANS;
ISOFLAVONES;
MALE;
NEOPLASMS, EXPERIMENTAL;
PROSTATIC NEOPLASMS;
RATS;
RESEARCH DESIGN;
TOXICITY TESTS;
|
|
EID: 0030324994
PISSN: 07331959
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (25)
|
|
References (0)
|